Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (121-130 of 407) with videos related to

Pageof 41
Sort By:
BMC Medicine|December 17, 2020
Mapping the cryptic spread of the 2015-2016 global Zika virus epidemicHaoyang Sun, Borame L Dickens, Mark Jit, et al.
BMJ Global Health|July 10, 2023
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countriesAnn Levin, Colleen Burgess, Stephanie Shendale, et al.
Epidemics|September 18, 2016
Clustering of contacts relevant to the spread of infectious diseaseXiong Xiao, Albert Jan van Hoek, Michael G Kenward, et al.
Vaccine|July 16, 2023
Vaccine Value ProfilesBirgitte Giersing, Ruth Karron, Marta Tufet-Bayona, et al.
BMJ Global Health|September 21, 2018
Determining environmental and anthropogenic factors which explain the global distribution of <i>Aedes aegypti</i> and <i>Ae. albopictus</i>Borame Lee Dickens, Haoyang Sun, Mark Jit, et al.
Vaccine|May 13, 2014
Evaluating the potential risks and benefits of infant rotavirus vaccination in EnglandAndy Clark, Mark Jit, Nick Andrews, et al.
Vaccine|October 23, 2012
The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in EnglandAlbert Jan van Hoek, Yoon Hong Choi, Caroline Trotter, et al.
Tropical Medicine & International Health : TM & IH|August 10, 2016
Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare systemTharani Loganathan, Mark Jit, Raymond Hutubessy, et al.
Nature Medicine|June 18, 2020
Age-dependent effects in the transmission and control of COVID-19 epidemicsNicholas G Davies, Petra Klepac, Yang Liu, et al.
BMJ Global Health|March 23, 2025
Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysisMegan Auzenbergs, Kaja Abbas, Corey M Peak, et al.
Pageof 41

Showing results (121-130 of 407) with videos related to

Sort By:
Pageof 41
BMC Medicine|December 17, 2020
Mapping the cryptic spread of the 2015-2016 global Zika virus epidemicHaoyang Sun, Borame L Dickens, Mark Jit, et al.
BMJ Global Health|July 10, 2023
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countriesAnn Levin, Colleen Burgess, Stephanie Shendale, et al.
Epidemics|September 18, 2016
Clustering of contacts relevant to the spread of infectious diseaseXiong Xiao, Albert Jan van Hoek, Michael G Kenward, et al.
Vaccine|July 16, 2023
Vaccine Value ProfilesBirgitte Giersing, Ruth Karron, Marta Tufet-Bayona, et al.
BMJ Global Health|September 21, 2018
Determining environmental and anthropogenic factors which explain the global distribution of <i>Aedes aegypti</i> and <i>Ae. albopictus</i>Borame Lee Dickens, Haoyang Sun, Mark Jit, et al.
Vaccine|May 13, 2014
Evaluating the potential risks and benefits of infant rotavirus vaccination in EnglandAndy Clark, Mark Jit, Nick Andrews, et al.
Vaccine|October 23, 2012
The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in EnglandAlbert Jan van Hoek, Yoon Hong Choi, Caroline Trotter, et al.
Tropical Medicine & International Health : TM & IH|August 10, 2016
Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare systemTharani Loganathan, Mark Jit, Raymond Hutubessy, et al.
Nature Medicine|June 18, 2020
Age-dependent effects in the transmission and control of COVID-19 epidemicsNicholas G Davies, Petra Klepac, Yang Liu, et al.
BMJ Global Health|March 23, 2025
Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysisMegan Auzenbergs, Kaja Abbas, Corey M Peak, et al.
Pageof 41